Innovative drug out-licensing deal value (half year)
China · as of 30 Jun 2026
Innovative drug out-licensing deal value in China (half year) stood at 110 billion USD as of 30 June 2026 (NHSA).
- Publisher
- NHSA
- Authority tier
- T1 Official
- Locator
- 我国上半年创新药对外授权约1100亿美元 创历史新高
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
最新统计显示,截至6月30日,我国创新药对外授权共81笔,交易总额约1100亿美元,达2025全年对外授权交易总额的80%。
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Other sources disagree
3 records report a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.
| Value | Divergence | Source organisation | Document | Locator | Details |
|---|---|---|---|---|---|
| 100 billion USD | -9.1% | State Council | Value of China's innovative drug out-licensing deals hit new high in H1 | Value of China's innovative drug out-licensing deals hit new high in H1 | Open record |
| 100 billion USD | -9.1% | State Council | China to expand health insurance coverage for innovative drugs | China to expand health insurance coverage for innovative drugs | Open record |
| 100 billion USD | -9.1% | MOFCOM | 上半年我国创新药对外技术授权交易额创新高 | 上半年我国创新药对外技术授权交易额创新高 | Open record |
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- National Healthcare Security Administration. (2026). 国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Via StatOrigin, https://statorigin.org/stat/stat_F85GSED465D9XYBVEA15Y0SHN0
- MLA
- National Healthcare Security Administration. "国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元." 2026, http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_F85GSED465D9XYBVEA15Y0SHN0.
- Chicago
- National Healthcare Security Administration. "国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元." 2026. http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_F85GSED465D9XYBVEA15Y0SHN0.
- BibTeX
- @misc{nhsa2026innovativey0shn0, author = {{National Healthcare Security Administration}}, title = {国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_F85GSED465D9XYBVEA15Y0SHN0}, note = {Original source: http://www.nhsa.gov.cn/art/2026/7/14/art\_14\_21423.html. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary Source
- Publisher
- National Healthcare Security Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元
- Type
- Press release
- Published
- —
- Locator
- 我国上半年创新药对外授权约1100亿美元 创历史新高
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_F85GSED465D9XYBVEA15Y0SHN0